# North Atlantic Smaller Companies NAV rises 7.7% in first half

- Link: https://www.directorstalkinterviews.com/north-atlantic-smaller-companies-nav-rises-7-7-in-first-half/4121263139
- Published: 2026-09-21T07:06:00+01:00
- Author: Amilia Stone

**North Atlantic Smaller Companies Investment Trust plc** (LON:NAS) has announced
its Half-Yearly Report for the six months ended 31 July 2026

North Atlantic Smaller Companies Investment Trust plc is a company incorporated 
and registered in England and Wales.

The objective of the Company is to provide capital appreciation through investment
in a portfolio of smaller companies principally based in countries bordering the
North Atlantic Ocean.

|  | **31 July****2026****(unaudited)** | 31 January2026(audited) |  %Change | 
| Net asset value (“NAV”) per 0.5p Ordinary Share*: |  |  |  | 
| Basic and diluted | **598.1p** | 555.4p | 7.7 | 
| Basic and diluted adjusted# | **639.0p** | 591.5p | 8.0 | 
| Market price of the 0.5p Ordinary Shares | **424.0p** | 359.0p | 18.1 | 
| Discount to net asset value | **29.1%** | 35.4% |  | 
| Discount to adjusted net asset value | **33.6%** | 39.3% |  | 
| Standard & Poor’s 500 Composite Index† | **5,562.4** | 5,061.7 | 9.9 | 
| Russell 2000 Index† | **2,177.0** | 1,906.6 | 14.2 | 
| Ongoing charges (annualised) | **1.2%** | 1.2% |  | 
| * Includes current period revenue. |  |  |  |

# Adjusted to reflect Oryx International Growth Fund Limited (“Oryx”) under the 
equity method of accounting. See note 6.

† Sterling adjusted.

## Chief Executive’s Review

During the six months under review the total return to shareholders of 9% was very
marginally behind the Sterling Adjusted Standard & Poors Composite Index. Once again,
technology performed well and major oil companies in particular out performed. Sterling
fell against the dollar which impacted relative performance as the dollar related
assets were now accounting for less than 20% of the portfolio.

The Company generated an income profit for the period of £5,953,000 a fall against
the corresponding period last year of £8,522,000. This fall results from lower short
term rates combined with the sale of some relatively high yielding securities to
fund the share buy back. Consistent with prior years, no dividend is being declared
until the outcome of the year becomes clearer. However, based on current expectations,
it is anticipated that the dividend for the current year will be at least 6pps and
hopefully a maintained 7pps.

The Company purchased for cancellation 5,305,000 shares during the period reducing
the number of shares outstanding to 125,195,000 at the end of the period. The shares
were purchased at a discount to the net assets of a little over 30% and will therefore
benefit all long term shareholders. It is perhaps worth noting that since I became
Chief Executive of the Trust approximately 132 million shares, or share equivalents,
have been purchased for cancellation. It is expected that further purchases will
be made over the next six months.

## Quoted Portfolio

Once again President Trump managed to cause considerable volatility in equity markets
over the six months as he launched a war against Iran. The result being soaring 
energy prices and further consumer uncertainty with the likelihood of food price
led inflation later in the year.

The value of the Trust’s holding in Oryx and Odyssean rose by 8.1%. Animalcare as
a result of a bid rose by 20%. Conduit continued to recover rising by just under
13%. Spire rose by 56% on a bid approach. Tate & Lyle rose by 47% as a result of
a takeover. Polar Capital rose by 31% as technology stocks boomed on Wall Street
whilst TP ICAP rose 34% as volatility in the bond and equity markets led to earnings
upgrades.

The major disappointment was Gleeson PLC which fell by nearly 30% as the failure
of the government’s housing policies has led to downgrades across the housebuilding
sector with a real risk of bankruptcies in some of the more financially exposed 
businesses.

In the US our sole quoted holding, Mountain Commerce, was taken over at approximately
five times original cost.

## Unquoted Portfolio

The majority of Coventbridge and Medica Packaging (an investment in Harwood Private
Equity V) were sold during the period, both at good profits to original cost and
brought in about £23m in cash. Another investment has started the process to be 
sold and should this be successful a further £9m in cash could be received by Christmas.

Two new unquoted investments were made as we participated in public to private in
two of our quoted investments, Frenkel Topping and Animalcare (£34m and £17.0m respectively
including our pro rata share of Harwood Private VI).

Both of these companies are very well known to us and I am highly confident will
add significant value to the Trust over the medium term.

## Outlook

The UK market continues to suffer from apparently endless redemptions as fund managers
pivot towards large international businesses whilst small cap and mid cap managers
who have not been lucky enough to benefit from takeovers suffer from poor performance.

UK interest rates have continued to rise at the long end and this combined with 
a plethora of proposed give aways by the new Burnham administration does not bode
well for government deficits or consumer confidence if they are funded by a further
massive round of tax rises.

Whilst the government bemoans the lack of interest in UK equities, it is hardly 
surprising when any sector that is doing well is hit with punitive taxation, banks,
oil companies and homebuilders in particular.

Equally depressing is the lack of support for our life science industries where 
businesses are now curtailing investment in the UK in favour of the United States.
Meanwhile the tax assault on the leisure sector is creating redundancies, youth 
unemployment and in some cases bankruptcies.

The weekly takeover of British companies continues meaning that the gene pool of
good quoted companies is shrinking which will inevitably have consequences over 
the medium term for the Trust.

C H B Mills

Chief Executive

20 September 2026

[SMrj7PZ8.content](https://www.directorstalkinterviews.com/wp-content/uploads/2026/09/SMrj7PZ8.content.pdf)
[Download](https://www.directorstalkinterviews.com/wp-content/uploads/2026/09/SMrj7PZ8.content.pdf)

Share on:
